Covey Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-7,432
Closed -$440K 51
2015
Q3
$440K Buy
7,432
+14
+0.2% +$888 0.25% 35
2015
Q2
$494K Buy
7,418
+15
+0.2% +$989 0.29% 33
2015
Q1
$478K Buy
7,403
+15
+0.2% +$939 0.29% 28
2014
Q4
$436K Buy
7,388
+15
+0.2% +$846 0.26% 29
2014
Q3
$377K Buy
+7,373
New +$368K 0.24% 32
2014
Q2
Hold
0
34
2014
Q1
Sell
-9,306
Closed -$495K 34
2013
Q4
$495K Buy
+9,306
New +$474K 0.28% 33

Other funds holding BMY

Covey Capital Advisors's BMY Position: Q4 2015 in Review

Covey Capital Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2015, closing a stake of 7,432 shares — an estimated $440K sold.

Covey Capital Advisors first reported a position in BMY in Q4 2013 and held it in 6 quarters. The position peaked at $495K in Q4 2013. 1,534 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

  • Covey Capital Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2015 after selling out during the quarter.
  • Covey Capital Advisors sold 7,432 Bristol-Myers Squibb shares in Q4 2015, an estimated $440K.
  • Covey Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 6 quarters.
  • Covey Capital Advisors's Bristol-Myers Squibb position peaked at $495K in Q4 2013.
  • 1,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Covey Capital Advisors's 13F filing for Q4 2015, filed 10 Feb 2016.